Heme oxygenase/carbon monoxide-biliverdin pathway may be involved in the antinociceptive activity of etoricoxib, a selective COX-2 inhibitor

Pharmacological Reports

Volumn 63, Issue 1, 2011, Pages 112-119

  Grangeiro, Niedja M G ^a   Aguiar, Jordana A ^a   Chaves, Hellíada V ^b   Silva, Antonio A R ^b   Lima, Vilma ^a   Benevides, Norma M B ^b   Brito, Gerly A C ^b   Da Graça, José R V ^a   Bezerra, Mirna M ^a  

^a Federal University of Ceará   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Antinociception; Etoricoxib; Heme oxygenase; Mice

Indexed keywords

BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; CYCLOOXYGENASE 2; ETORICOXIB; HEME OXYGENASE 1; HEMIN; INDOMETACIN; OXIDOREDUCTASE; PROTOPORPHYRIN ZINC;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME INHIBITION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PERITONEUM EXUDATE;

EID: 79953224880     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70405-4     Document Type: Article

References (40)

1. Alcaraz MJ, Fernández P, Guillén MI: Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des, 2003, 9, 2541-2551. (Pubitemid 37236372)
2. Bednarz N, Zawacka-Pankau J, Kowalska A: Protoporphyrin IX induces apoptosis in HeLa cells prior to photodynamic treatment. Pharmacol Rep, 2007, 59, 474-479. (Pubitemid 47558821)
3. Bezerra MM, Lima V, Girão VCC, Teixeira RC, Graça JRV: Antinociceptive activity of sildenafil and adrenergic agents in the writhing test in mice. Pharmacol Rep, 2008, 60, 339-344.
4. Botros FT, Schwartzman ML, Stier CT, Goodman AI, Abraham NG: Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int, 2005, 68, 2745-2755. (Pubitemid 43251019)
5. Bressan E, Tonussi CR: Antiinflammatory effects of etoricoxib alone and combined with NSAIDs in LPS-induced reactive arthritis. Inflamm Res, 2008, 57, 586-592.
6. Choi HC, Kim HS, Lee KY, Chang KC, Kang YJ: NS-398, a selective COX-2 inhibitor, inhibits proliferation of IL-1β-stimulated vascular smooth muscle cells by induction of HO-1. Biochem Biophys Res Commun, 2008, 376, 753-757.
7. Datta PK, Lianos EA: Nitric oxide induces heme oxygenase-1 gene expression in mesanglial cells. Kidney Int, 1999, 55, 1734-1739. (Pubitemid 29197960)
8. +, x = 1-6. J Am Chem Soc, 1989, 111, 2401-2409.
9. Ferreira SH, Duarte IDG, Lorenzetti BB: The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol, 1991, 201, 121-122.
10. Freitas A, Alves-Filho JC, Secco DD, Neto AF, Ferreira SH, Barja-Fidalgo C, Cunha FQ: Heme oxygenase/carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br J Pharmacol, 2006, 149, 345-354. (Pubitemid 44582241)
11. Fürst R, Blumenthal SB, Kiemer AK, Zahler S, Vollmar AM: Nuclear factor-κB-independent anti-inflammatory action of salicylate in human endothelial cells: Induction of heme oxygenase-1 by the c-Jun N-terminal kinase/activator protein-1 pathway. J Pharmacol Exp Ther, 2006, 318, 389-394.
12. Grangeiro NMGC, Chaves HV, Silva AAR, Graça JRV, Lima V, Bezerra MM: Cyclooxygenase 1 and 2 enzymes: inflammation, gastric and cardio protection (Portuguese). Revista Eletrônica Pesquisa Médica, 2008, 3, 14-18.
13. Haider A, Olszanecki R, Gryglewski R, Schwartzman ML, Lianos E, Kappas A, Nasjletti A et al.: Regulation of cyclooxygenase by the heme-heme oxygenase system in microvessel endothelial cells. J Pharmacol Exp Ther, 2002, 300, 188-194. (Pubitemid 34028526)
14. Hunt RH, Harper S, Callegari P, Yu C, Quan H, Evans J, James C et al.: Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2- selective inhibitor etoricoxib. Aliment Pharmacol Ther, 2003, 17, 201-210. (Pubitemid 36174250)
15. Johnson TR, Mann BE, Clark JE, Foresti R, Green CJ, Motterlini M: Metal carbonyls: a new class of pharmaceuticals? Angew Chem Int Ed, 2003, 42, 3722-3729.
16. Kladna A, Aboul-Enein HY, Kruk I, Lichszteld K, Michalska T: Scavenging of reactive oxygen species by some nonsteroidal anti-inflammatory drugs and fenofibrate. Biopolymers, 2006, 82, 99-105. (Pubitemid 43798158)
17. Le Bars D, Gozariu M, Cadden SW: Animal models of nociception. Pharmacol Rev, 2001, 53, 597-652. (Pubitemid 33136239)
18. Lefkowith JB: Cyclooxygenase-2 specificity and its clinical implications. Am J Med, 1999, 106, 43S-50S.
19. Lennon AM, Ramauge M, Pierre M: Role of redox status on the activation of mitogen-activated protein kinase cascades by NSAIDs. Biochem Pharmacol, 2002, 63, 163-170. (Pubitemid 34158816)
20. Lima V, Silva CB, Mafezoli J, Bezerra MM, Moraes MO, Mourão GSMM, Silva JN, Oliveira MCF: Antinociceptive activity of the pyranocoumarin seselin in mice. Fitoterapia, 2006, 77, 574-578. (Pubitemid 44738285)
21. Lipsky LP, Abramson SB, Crofford L, Dubois RN, Simon LS, van de Putte LB: The classification of cyclooxygenase inhibitors. J Rheumatol, 1998, 25, 2298-2303. (Pubitemid 28551843)
22. Maines MD: Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J, 1988, 2, 2557-2568.
23. Majewska M, Zaja̧c K, Dulak J, Szczepanik M: Heme oxygenase (HO-1) is involved in the negative regulation of contact sensitivity reaction. Pharmacol Rep, 2008, 60, 933-940.
24. McCoubrey WK, Huang TJ, Maines MD: Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem, 1997, 247, 725-732. (Pubitemid 27308655)
25. Medhi B, Sukhija M, Prakash A, Gaikwad S, Bansal V, Pandhi P: Effects of etoricoxib on the pharmacokinetics of phenytoin. Pharmacol Rep, 2008, 60, 233-237.
26. Morita T, Perrella MA, Lee ME, Kourembanas S: Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA, 1995, 92, 1475-1479.
27. Nivsarkar M: Improvement in circulating superoxide dismutase levels: role of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Biochem Biophys Res Commun, 2000, 270, 714-716.
28. Nivsarkar M, Banerjee A, Padh H: Cyclooxygenase inhibitors: a novel direction for Alzheimer's management. Pharmacol Rep, 2008, 60, 692-698.
29. Oshiro S, Takeuchi H, Matsumoto M, Kurata S: Transcriptional activation of heme oxygenase-1 gene in mouse spleen, liver and kidney cells after treatment with lipopolysaccharide or hemoglobin. Cell Biol Int, 1999, 23, 465-474. (Pubitemid 30125201)
30. Riendeau D, Brideau PC, Charleson S: Etoricoxib (MK-0663): Preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther, 2001, 296, 558-566. (Pubitemid 32112486)
31. Secco DD, Paron JA, de Oliveira SH, Ferreira SH, Silva JS, Cunha FQ: Neutrophil migration in inflammation: nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide, 2003, 9, 153-164. (Pubitemid 38081293)
32. Simon LS: Role and regulation of cyclooxygenase-2 during inflammation. Am J Med, 1999, 106, 37S-42S.
33. Smith WL, Garavito RM, DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem, 1996, 271, 33157-33160. (Pubitemid 27010118)
34. Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, Tsui TY, Bach FH: Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol, 2004, 172, 3553-3563. (Pubitemid 38337936)
35. Steiner AA, Branco LGS, Cunha FQ, Ferreira SH: Role of the haeme oxygenase/carbon monoxide pathway in mechanical nociceptor hypersensitivity. Br J Pharmacol, 2001, 132, 1673-1682. (Pubitemid 32397959)
36. Vachharajani TJ, Work J, Issekutz AC, Granger DN: Heme oxygenase modulates selectin expression in different regional vascular beds. Am J Physiol Heart Circ Physiol, 2000, 278, H1613-H1617. (Pubitemid 30395574)
37. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature, 1971, 231, 232-235.
38. Vane JR: Towards a better aspirin. Nature, 1994, 367, 215-216.
39. Vane JR, Warner TD: Nomenclature for COX-2 inhibitors. Lancet, 2000, 356, 1373-1374.
40. Vicente AM, Guillen MI, Habib A, Alcaraz MJ: Beneficial effects of heme oxygenase-1 up-regulation in the development of experimental inflammation induced by zymosan. J Pharmacol Exp Ther, 2003, 307, 1030-1037. (Pubitemid 37494222)